RIPE-KG · Version 1.1.0 · Resource

ripekg:work/10.1007%2Fs43440-020-00195-y

https://w3id.org/ripe/ripe-kg/work/10.1007%2Fs43440-020-00195-y
SubjectPredicateObject
ripekg:work/10.1007%2Fs43440-020-00195-yIvermectin as a potential drug for treatment of COVID-19: An in-sync review with clinical and computational attributes prism:doi 10.1007/s43440-020-00195-y
ripekg:work/10.1007%2Fs43440-020-00195-yIvermectin as a potential drug for treatment of COVID-19: An in-sync review with clinical and computational attributes dcterms:title Ivermectin as a potential drug for treatment of COVID-19: An in-sync review with clinical and computational attributes
ripekg:work/10.1007%2Fs43440-020-00195-yIvermectin as a potential drug for treatment of COVID-19: An in-sync review with clinical and computational attributes rdf:type node1
ripekg:work/10.1007%2Fs43440-020-00195-yIvermectin as a potential drug for treatment of COVID-19: An in-sync review with clinical and computational attributes rdf:type http://purl.org/spar/fabio/Work
ripekg:work/10.1007%2Fs43440-020-00195-yIvermectin as a potential drug for treatment of COVID-19: An in-sync review with clinical and computational attributes rdf:type rdfs:Resource
ripekg:work/10.1007%2Fs43440-020-00195-yIvermectin as a potential drug for treatment of COVID-19: An in-sync review with clinical and computational attributes rdf:type owl:Thing
ripekg:work/10.1007%2Fs43440-020-00195-yIvermectin as a potential drug for treatment of COVID-19: An in-sync review with clinical and computational attributes rdf:type prov:Entity
ripekg:work/10.1007%2Fs43440-020-00195-yIvermectin as a potential drug for treatment of COVID-19: An in-sync review with clinical and computational attributes rdf:type ripe:WorkWork
ripekg:work/10.1007%2Fs43440-020-00195-yIvermectin as a potential drug for treatment of COVID-19: An in-sync review with clinical and computational attributes owl:sameAs https://semopenalex.org/work/W3120108340
ripekg:work/10.3390%2Fv13060989RETRACTED: Effects of a Single Dose of Ivermectin on Viral and Clinical Outcomes in Asymptomatic SARS-CoV-2 Infected Subjects: A Pilot Clinical Trial in Lebanon http://purl.org/spar/cito/cites ripekg:work/10.1007%2Fs43440-020-00195-yIvermectin as a potential drug for treatment of COVID-19: An in-sync review with clinical and computational attributes